PF9601N [N-(2-propynyl)-2-(5-benzyloxy-indolyl) methylamine] confers MAO-B independent neuroprotection in ER stress-induced cell death

Molecular and Cellular Neuroscience

Volumn 41, Issue 1, 2009, Pages 19-31

  Sanz, Elisenda ^a   Quintana, Albert ^b   Hidalgo, Juan ^b   Marco, Jose Luis ^c   Unzeta, Mercedes ^a  

^a Facultat de Medicina   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c INSTITUTO DE QUÍMICA ORGÁNICA GENERAL   (Spain)

Author keywords

Apoptosis; Brefeldin A; Endoplasmic reticulum stress; PF9601N; Unfolded protein response

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; MONOAMINE OXIDASE B INHIBITOR; N(2 PROPYNYL) 2 (5 BENZYLOXY INDOLYL)METHYLAMINE; NEUROPROTECTIVE AGENT; PF 9601 N; UNCLASSIFIED DRUG;

ARTICLE; CELL DEATH; CELL DISRUPTION; CONTROLLED STUDY; DISEASE MODEL; ENDOPLASMIC RETICULUM STRESS; GOLGI COMPLEX; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; NEUROPROTECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; BREFELDIN A; CASPASE 2; CASPASE 9; CELL DEATH; CELL LINE, TUMOR; DNA-BINDING PROTEINS; ENDOPLASMIC RETICULUM; HUMANS; INDOLES; MONOAMINE OXIDASE; MONOAMINE OXIDASE INHIBITORS; NEUROPROTECTIVE AGENTS; PROTEIN SYNTHESIS INHIBITORS; STRESS, PHYSIOLOGICAL; TRANSCRIPTION FACTOR CHOP; TRANSCRIPTION FACTORS; TUNICAMYCIN;

EID: 64849103267     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcn.2009.01.005     Document Type: Article

References (71)

1. Averous J., Bruhat A., Jousse C., Carraro V., Thiel G., and Fafournoux P. Induction of CHOP expression by amino acid limitation requires both ATF4 expression and ATF2 phosphorylation. J. Biol. Chem. 279 (2004) 5288-5297
2. Avila M., Balsa M.D., Fernandez-Alvarez E., Tipton K.F., and Unzeta M. The effect of side chain substitution at positions 2 and 3 of the heterocyclic ring of N-acetylenic analogues of tryptamine as monoamine oxidase inhibitors. Biochem. Pharmacol. 45 (1993) 2231-2237
3. Baliga B.C., Read S.H., and Kumar S. The biochemical mechanism of caspase-2 activation. Cell Death Differ. 11 (2004) 1234-1241
4. Balsa D., Fernandez-Alverez E., Tipton K.F., and Unzeta M. Monoamine oxidase inhibitory potencies and selectivities of 2-[N-(2-propynyl)-aminomethyl]-1-methyl indole derivatives. Biochem. Soc. Trans. 19 (1991) 215-218
5. Balsa D., Perez V., Fernandez-Alvarez E., and Unzeta M. Kinetic behaviour of some acetylenic indolalkylamine derivatives and their corresponding parent amines. J. Neural Transm., Suppl. 41 (1994) 281-285
6. Battaglia V., Sanz E., Salvi M., Unzeta M., and Toninello A. Protective effect of N-(2-propynyl)-2-(5-benzyloxy-indolyl) methylamine (PF9601N) on mitochondrial permeability transition. Cell. Mol. Life Sci. 63 (2006) 1440-1448
7. Bruhat A., Jousse C., Carraro V., Reimold A.M., Ferrara M., and Fafournoux P. Amino acids control mammalian gene transcription: activating transcription factor 2 is essential for the amino acid responsiveness of the CHOP promoter. Mol. Cell. Biol. 20 (2000) 7192-7204
8. Burke R.E. Programmed cell death and new discoveries in the genetics of parkinsonism. J. Neurochem. 104 (2008) 875-890
9. Cheung H.H., Lynn Kelly N., Liston P., and Korneluk R.G. Involvement of caspase-2 and caspase-9 in endoplasmic reticulum stress-induced apoptosis: a role for the IAPs. Exp. Cell Res. 312 (2006) 2347-2357
10. Cruces M.A., Elorriaga C., and Fernandez-Alvarez E. The kinetics of monoamine oxidase inhibition by three 2-indolylmethylamine derivatives. Biochem. Pharmacol. 40 (1990) 535-543
11. Cutillas B., Ambrosio S., and Unzeta M. Neuroprotective effect of the monoamine oxidase inhibitor PF 9601N [N-(2-propynyl)-2-(5-benzyloxy-indolyl) methylamine] on rat nigral neurons after 6-hydroxydopamine-striatal lesion. Neurosci. Lett. 329 (2002) 165-168
12. Dahmer M.K. Caspases-2, -3, and -7 are involved in thapsigargin-induced apoptosis of SH-SY5Y neuroblastoma cells. J. Neurosci. Res. 80 (2005) 576-583
13. DeGracia D.J., and Montie H.L. Cerebral ischemia and the unfolded protein response. J. Neurochem. 91 (2004) 1-8
14. Fischer H., Koenig U., Eckhart L., and Tschachler E. Human caspase 12 has acquired deleterious mutations. Biochem. Biophys. Res. Commun. 293 (2002) 722-726
15. Fowler C.J., and Tipton K.F. Concentration dependence of the oxidation of tyramine by the two forms of rat liver mitochondrial monoamine oxidase. Biochem. Pharmacol. 30 (1981) 3329-3332
16. Guo Y., Srinivasula S.M., Druilhe A., Fernandes-Alnemri T., and Alnemri E.S. Caspase-2 induces apoptosis by releasing proapoptotic proteins from mitochondria. J. Biol. Chem. 277 (2002) 13430-13437
17. Harding H.P., Zhang Y., and Ron D. Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase. Nature 397 (1999) 271-274
18. Harding H.P., Novoa I., Zhang Y., Zeng H., Wek R., Schapira M., and Ron D. Regulated translation initiation controls stress-induced gene expression in mammalian cells. Mol. Cell 6 (2000) 1099-1108
19. Haze K., Yoshida H., Yanagi H., Yura T., and Mori K. Mammalian transcription factor ATF6 is synthesized as a transmembrane protein and activated by proteolysis in response to endoplasmic reticulum stress. Mol. Biol. Cell 10 (1999) 3787-3799
20. Hetz C., Russelakis-Carneiro M., Maundrell K., Castilla J., and Soto C. Caspase-12 and endoplasmic reticulum stress mediate neurotoxicity of pathological prion protein. EMBO J. 22 (2003) 5435-5445
21. Hitomi J., Katayama T., Eguchi Y., Kudo T., Taniguchi M., Koyama Y., Manabe T., Yamagishi S., Bando Y., Imaizumi K., Tsujimoto Y., and Tohyama M. Involvement of caspase-4 in endoplasmic reticulum stress-induced apoptosis and Abeta-induced cell death. J. Cell Biol. 165 (2004) 347-356
22. Holtz W.A., and O'Malley K.L. Parkinsonian mimetics induce aspects of unfolded protein response in death of dopaminergic neurons. J. Biol. Chem. 278 (2003) 19367-19377
23. Hoozemans J.J., Veerhuis R., Van Haastert E.S., Rozemuller J.M., Baas F., Eikelenboom P., and Scheper W. The unfolded protein response is activated in Alzheimer's disease. Acta Neuropathol. 110 (2005) 165-172
24. Hoozemans J.J., van Haastert E.S., Eikelenboom P., de Vos R.A., Rozemuller J.M., and Scheper W. Activation of the unfolded protein response in Parkinson's disease. Biochem. Biophys. Res. Commun. 354 (2007) 707-711
25. Ilieva E.V., Ayala V., Jove M., Dalfo E., Cacabelos D., Povedano M., Bellmunt M.J., Ferrer I., Pamplona R., and Portero-Otin M. Oxidative and endoplasmic reticulum stress interplay in sporadic amyotrophic lateral sclerosis. Brain 130 (2007) 3111-3123
26. Iwawaki T., Akai R., Kohno K., and Miura M. A transgenic mouse model for monitoring endoplasmic reticulum stress. Nat. Med. 10 (2004) 98-102
27. Larner S.F., Hayes R.L., McKinsey D.M., Pike B.R., and Wang K.K. Increased expression and processing of caspase-12 after traumatic brain injury in rats. J. Neurochem. 88 (2004) 78-90
28. Larner S.F., Hayes R.L., and Wang K.K. Unfolded protein response after neurotrauma. J. Neurotrauma. 23 (2006) 807-829
29. Machamer C.E. Golgi disassembly in apoptosis: cause or effect?. Trends Cell Biol. 13 (2003) 279-281
30. Magyar K., Palfi M., Jenei V., and Szoko E. Deprenyl: from chemical synthesis to neuroprotection. J. Neural Transm., Suppl. (2006) 143-156
31. Mandel S., Weinreb O., Amit T., and Youdim M.B. Mechanism of neuroprotective action of the anti-Parkinson drug rasagiline and its derivatives. Brain Res. Brain Res. Rev. 48 (2005) 379-387
32. Matsumoto M., Minami M., Takeda K., Sakao Y., and Akira S. Ectopic expression of CHOP (GADD153) induces apoptosis in M1 myeloblastic leukemia cells. FEBS Lett. 395 (1996) 143-147
33. Maytin E.V., Ubeda M., Lin J.C., and Habener J.F. Stress-inducible transcription factor CHOP/gadd153 induces apoptosis in mammalian cells via p38 kinase-dependent and -independent mechanisms. Exp. Cell Res. 267 (2001) 193-204
34. McCullough K.D., Martindale J.L., Klotz L.O., Aw T.Y., and Holbrook N.J. Gadd153 sensitizes cells to endoplasmic reticulum stress by down-regulating Bcl2 and perturbing the cellular redox state. Mol. Cell. Biol. 21 (2001) 1249-1259
35. McStay G.P., Salvesen G.S., and Green D.R. Overlapping cleavage motif selectivity of caspases: implications for analysis of apoptotic pathways. Cell Death Differ. 15 (2008) 322-331
36. Murakami Y., Aizu-Yokota E., Sonoda Y., Ohta S., and Kasahara T. Suppression of endoplasmic reticulum stress-induced caspase activation and cell death by the overexpression of Bcl-xL or Bcl-2. J. Biochem. 141 (2007) 401-410
37. Nakagawa T., Zhu H., Morishima N., Li E., Xu J., Yankner B.A., and Yuan J. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature 403 (2000) 98-103
38. Nakagomi S., Barsoum M.J., Bossy-Wetzel E., Sutterlin C., Malhotra V., and Lipton S.A. A Golgi fragmentation pathway in neurodegeneration. Neurobiol. Dis. 29 (2008) 221-231
39. Ni M., and Lee A.S. ER chaperones in mammalian development and human diseases. FEBS Lett. 581 (2007) 3641-3651
40. Nishitoh H., Matsuzawa A., Tobiume K., Saegusa K., Takeda K., Inoue K., Hori S., Kakizuka A., and Ichijo H. ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats. Genes Dev. 16 (2002) 1345-1355
41. Obeng E.A., and Boise L.H. Caspase-12 and caspase-4 are not required for caspase-dependent endoplasmic reticulum stress-induced apoptosis. J. Biol. Chem. 280 (2005) 29578-29587
42. Oyadomari S., and Mori M. Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ. 11 (2004) 381-389
43. Oyadomari S., Koizumi A., Takeda K., Gotoh T., Akira S., Araki E., and Mori M. Targeted disruption of the Chop gene delays endoplasmic reticulum stress-mediated diabetes. J. Clin. Invest. 109 (2002) 525-532
44. Penas C., Guzman M.S., Verdu E., Fores J., Navarro X., and Casas C. Spinal cord injury induces endoplasmic reticulum stress with different cell-type dependent response. J. Neurochem. 102 (2007) 1242-1255
45. Pereira N.A., and Song Z. Some commonly used caspase substrates and inhibitors lack the specificity required to monitor individual caspase activity. Biochem. Biophys. Res. Commun. 377 (2008) 873-877
46. Perez V., and Unzeta M. PF 9601N [N-(2-propynyl)-2-(5-benzyloxy-indolyl) methylamine], a new MAO-B inhibitor, attenuates MPTP-induced depletion of striatal dopamine levels in C57/BL6 mice. Neurochem. Int. 42 (2003) 221-229
47. Perez V., Marco J.L., Fernandez-Alvarez E., and Unzeta M. Kinetic studies of N-allenic analogues of tryptamine as monoamine oxidase inhibitors. J. Pharm. Pharmacol. 48 (1996) 718-722
48. Perez V., Marco J.L., Fernandez-Alvarez E., and Unzeta M. Relevance of benzyloxy group in 2-indolyl methylamines in the selective MAO-B inhibition. Br. J. Pharmacol. 127 (1999) 869-876
49. Perez V., Moron J., Pasto M., and Unzeta M. Neuroprotective aspects of a novel MAO-B inhibitor PF9601N. Neurobiology (Bp.) 8 (2000) 231-236
50. Perez V., Romera M., Lizcano J.M., Marco J.L., and Unzeta M. Protective effect of N-(2-propynyl)-2-(5-benzyloxyindolyl) methylamine (PF 9601N), a novel MAO-B inhibitor, on dopamine-lesioned PC12 cultured cells. J. Pharm. Pharmacol. 55 (2003) 713-716
51. Prat G., Perez V., Rubi A., Casas M., and Unzeta M. The novel type B MAO inhibitor PF9601N enhances the duration of L-DOPA-induced contralateral turning in 6-hydroxydopamine lesioned rats. J. Neural Transm. 107 (2000) 409-417
52. Prostko C.R., Brostrom M.A., and Brostrom C.O. Reversible phosphorylation of eukaryotic initiation factor 2 alpha in response to endoplasmic reticular signaling. Mol. Cell. Biochem. 127-128 (1993) 255-265
53. Reijonen S., Putkonen N., Norremolle A., Lindholm D., and Korhonen L. Inhibition of endoplasmic reticulum stress counteracts neuronal cell death and protein aggregation caused by N-terminal mutant huntingtin proteins. Exp. Cell Res. 314 (2008) 950-960
54. Riederer P., and Youdim M.B. Monoamine oxidase activity and monoamine metabolism in brains of parkinsonian patients treated with l-deprenyl. J. Neurochem. 46 (1986) 1359-1365
55. Robertson J.D., Enoksson M., Suomela M., Zhivotovsky B., and Orrenius S. Caspase-2 acts upstream of mitochondria to promote cytochrome c release during etoposide-induced apoptosis. J. Biol. Chem. 277 (2002) 29803-29809
56. Ryoo H.D., Domingos P.M., Kang M.J., and Steller H. Unfolded protein response in a Drosophila model for retinal degeneration. EMBO J. 26 (2007) 242-252
57. Ryu E.J., Harding H.P., Angelastro J.M., Vitolo O.V., Ron D., and Greene L.A. Endoplasmic reticulum stress and the unfolded protein response in cellular models of Parkinson's disease. J. Neurosci. 22 (2002) 10690-10698
58. Sanz E., Romera M., Bellik L., Marco J.I., and Unzeta M. Indolalkylamines derivatives as antioxidant and neuroprotective agents in an experimental model of Parkinson's disease. Med. Sci. Monit. 10 (2004) BR477-BR484
59. Sanz E., Quintana A., Battaglia V., Toninello A., Hidalgo J., Ambrosio S., Valoti M., Marco J.L., Tipton K.F., and Unzeta M. Anti-apoptotic effect of Mao-B inhibitor PF9601N [N-(2-propynyl)-2-(5-benzyloxy-indolyl) methylamine] is mediated by p53 pathway inhibition in MPP(+)-treated SH-SY5Y human dopaminergic cells. J. Neurochem. 105 6 (2008) 2404-2417
60. Schapira A.H. Mitochondria in the aetiology and pathogenesis of Parkinson's disease. Lancet Neurol. 7 (2008) 97-109
61. Silva R.M., Ries V., Oo T.F., Yarygina O., Jackson-Lewis V., Ryu E.J., Lu P.D., Marciniak S.J., Ron D., Przedborski S., Kholodilov N., Greene L.A., and Burke R.E. CHOP/GADD153 is a mediator of apoptotic death in substantia nigra dopamine neurons in an in vivo neurotoxin model of parkinsonism. J. Neurochem. 95 (2005) 974-986
62. Takano K., Kitao Y., Tabata Y., Miura H., Sato K., Takuma K., Yamada K., Hibino S., Choshi T., Iinuma M., Suzuki H., Murakami R., Yamada M., Ogawa S., and Hori O. A dibenzoylmethane derivative protects dopaminergic neurons against both oxidative stress and endoplasmic reticulum stress. Am. J. Physiol., Cell Physiol. 293 (2007) C1884-1894
63. Tatton W., Chalmers-Redman R., and Tatton N. Neuroprotection by deprenyl and other propargylamines: glyceraldehyde-3-phosphate dehydrogenase rather than monoamine oxidase B. J. Neural Transm. 110 (2003) 509-515
64. Upton J.P., Austgen K., Nishino M., Coakley K.M., Hagen A., Han D., Papa F.R., and Oakes S.A. Caspase-2 cleavage of BID is a critical apoptotic signal downstream of endoplasmic reticulum stress. Mol. Cell. Biol. 28 (2008) 3943-3951
65. Vila M., and Przedborski S. Targeting programmed cell death in neurodegenerative diseases. Nat. Rev., Neurosci. 4 (2003) 365-375
66. Wang H.Q., and Takahashi R. Expanding insights on the involvement of endoplasmic reticulum stress in Parkinson's disease. Antioxid. Redox Signal. 9 (2007) 553-561
67. Yamaguchi H., and Wang H.G. CHOP is involved in endoplasmic reticulum stress-induced apoptosis by enhancing DR5 expression in human carcinoma cells. J. Biol. Chem. 279 (2004) 45495-45502
68. Ye J., Rawson R.B., Komuro R., Chen X., Dave U.P., Prywes R., Brown M.S., and Goldstein J.L. ER stress induces cleavage of membrane-bound ATF6 by the same proteases that process SREBPs. Mol. Cell 6 (2000) 1355-1364
69. Yoshida H., Matsui T., Yamamoto A., Okada T., and Mori K. XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell 107 (2001) 881-891
70. Youdim M.B., Edmondson D., and Tipton K.F. The therapeutic potential of monoamine oxidase inhibitors. Nat. Rev., Neurosci. 7 (2006) 295-309
71. Zinszner H., Kuroda M., Wang X., Batchvarova N., Lightfoot R.T., Remotti H., Stevens J.L., and Ron D. CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum. Genes Dev. 12 (1998) 982-995